Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Amendment of Notice

---
identifier: "/us/fr/E6-20538"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Amendment of Notice"
title_number: 0
title_name: "Federal Register"
section_number: "E6-20538"
section_name: "Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Amendment of Notice"
positive_law: false
currency: "2006-12-05"
last_updated: "2006-12-05"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-20538"
document_type: "notice"
publication_date: "2006-12-05"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "71 FR 70518"
fr_volume: 71
fr_action: "Notice."
---


#  Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Amendment of Notice

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

The Food and Drug Administration (FDA) is announcing an amendment to the notice of joint meeting of the Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee. This meeting was announced in the *Federal Register* of November 15, 2006 (71 FR 66545). The amendment is being made to reflect a change in the *Location* portion of the document. There are no other changes.

**FOR FURTHER INFORMATION CONTACT:**

Sohail Mosaddegh, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857, 301-827-7001, fax: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington DC area), codes 301-451-2530 or 301-451-2535. Please call the Information Line for up-to-date information on this meeting.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of November 15, 2006, FDA announced that a joint meeting of Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee would be held on December 14 and 15, 2006. On page 66545, in the first column, the *Location* portion of document is amended to read as follows:

*Location* : Hilton, Maryland Ballrooms, 8727 Colesville Road, Silver Spring, MD. The hotel phone number is 301-589-5200.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

Dated: November 29, 2006.

Randall W. Lutter,

Associate Commissioner for Policy and Planning.